Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Clinical trial NCT07246590 · RECRUITING

Trial details

NCT number: NCT07246590
Sponsor: Verrica Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Common Warts Common Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)Warts

Start date: 2025-12-17
Primary completion: 2027-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.